Anja van Biezen
About
In The Last Decade
Anja van Biezen
95 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 79
- Hematology 2.5k
- Genetics 1.1k
- Public Health, Environmental and Occupational Health 761
- Immunology 513
- Oncology 489
Countries citing papers authored by Anja van Biezen
This map shows the geographic impact of Anja van Biezen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja van Biezen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja van Biezen more than expected).
Fields of papers citing papers by Anja van Biezen
This network shows the impact of papers produced by Anja van Biezen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja van Biezen. The network helps show where Anja van Biezen may publish in the future.
Co-authorship network of co-authors of Anja van Biezen
This figure shows the co-authorship network connecting the top 25 collaborators of Anja van Biezen. A scholar is included among the top collaborators of Anja van Biezen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja van Biezen. Anja van Biezen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 10 | |
| 4 | Mother donors improve outcomes after HLA haploidentical T cell-depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party of the EBMT | 2 |
| 5 | 23 | |
| 6 | 90 | |
| 7 | HUMAN LEUKOCYTE ANTIGEN MATCHING AND CONDITIONING IMPACT ON LONG-TERM TRANSPLANT OUTCOME AFTER ALLOGENEIC HSCT FOR CHRONIC LYMPHOCYTIC LEUKEMIA | 1 |
| 8 | 38 | |
| 9 | 25 | |
| 10 | In vivo T-cell depletion in allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: a retrospective EBMT analysis | 2 |
| 11 | 87 | |
| 12 | 10 | |
| 13 | Effect of cytogenetics classification according to IPSS on the outcome of allogeneic HSCT from HLA-identical siblings in patients with MDS or secondary AML : a retrospective analysis from the EBMT-CLWP | 1 |
| 14 | Allogeneic stem cell transplantation with matched related and unrelated donors for patients with refractory anemia: T-cell depletion and reduced intensity regimens are associated with increased relapse risk | 1 |
| 15 | Autologous peripheral stem cell transplantation of patients with high-risk MDS or AML following MDS results in equivalent outcome when compared to autologous bone marrow transplantation | 1 |
| 16 | 70 | |
| 17 | Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT) | 4 |
| 18 | 149 | |
| 19 | 87 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.